Per Falk joined Ferring Pharmaceuticals in 2015 and was appointed President on January 1st, 2019. Based in Saint-Prex, Switzerland.
Per Falk joined Ferring Pharmaceuticals in 2015 and was appointed President on January 1st, 2019. Prior to this, he held executive and senior leadership positions at Novo Nordisk and AstraZeneca. He also served as an Associate Professor at the Karolinska Institute, Sweden, and Washington University School of Medicine, USA.
Full founder directory · Investor directory · Company funding database · Fundraising library